Dividend Channel
Market News Video Dividend Detective The Warren Buffetts Next Door Stock message boards
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

IWP's Underlying Holdings Could Mean 15% Gain Potential
Thursday, November 29, 7:24 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

SRPT January 2019 Options Begin Trading
Thursday, November 29, 1:03 PM ET, by Market News Video Staff

Investors in Sarepta Therapeutics Inc (SRPT) saw new options begin trading today, for the January ...

Notable Friday Option Activity: TRU, SRPT, NLSN
Friday, December 14, 3:19 PM ET, by Market News Video Staff

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy ...

Relative Strength Alert For Sarepta Therapeutics
Wednesday, December 19, 12:04 PM ET, by Market News Video Staff

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...

How The Parts Add Up: FNY Headed For $48
Monday, December 31, 9:59 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

Top Buys by Directors: Ingram's $2M Bet on SRPT

By Dividend Channel Staff, Friday, February 15, 11:15 AM ET
Play Video: One Reason For Insiders to Buy

If the video does not load after a few moments, Upgrade to the Latest Flash Player.

The directors of a company tend to have a unique inside view into the business, so when directors make major buys, investors are wise to take notice. Presumably the only reason a director of a company would choose to take their hard-earned cash and use it to buy stock in the open market, is that they expect to make money maybe they find the stock very undervalued, or maybe they see exciting progress within the company, or maybe both. So in this series we look at the largest insider buys by company directors over the trailing six month period, one of which was a total of $2M by Douglas S. Ingram, CEO at Sarepta Therapeutics Inc (NASDAQ:SRPT).

Ingram bets big on SRPT:

Purchased Insider Title Shares Price/Share Value
10/30/2018 Douglas S. Ingram President & CEO 16,695 $120.39 $2,009,871.82

Ingram's average cost works out to $120.39/share. Shares of Sarepta Therapeutics Inc were changing hands at $136.53 at last check, trading up about 1.2% on Friday. The chart below shows the one year performance of SRPT shares, versus its 200 day moving average:

Sarepta Therapeutics Inc Chart

Looking at the chart above, SRPT's low point in its 52 week range is $59.505 per share, with $176.50 as the 52 week high point that compares with a last trade of $136.53.

Special Offer: Receive our best dividend ideas directly to your inbox each afternoon with the Dividend Channel Premium Newsletter

This Article's Word Cloud:   Buys   Channel   Company   Directors   Dividend   Douglas   Friday   Ingram   Insider   Looking   Newsletter   Offer   Premium   President   Presumably   Price   Purchased   Receive   SRPT   Sarepta   Share   Shares   Special   Start   Therapeutics   Title   Value   about   above   afternoon   average   below   best   bets   both   buys   chart   company   directors   last   make   maybe   point   share   stock   take   that   they   week   with

Top Buys by Directors: Ingram's $2M Bet on SRPT | www.DividendChannel.com | Copyright © 2010 - 2019, All Rights Reserved

Nothing in Dividend Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and dividend videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact Dividend Channel; Meet Our Editorial Staff.